Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.99T
24h Vol:
$9.86B
Dominance:
MSFT:5.13%
Stocklytics Platform
BETA
Instrument logo  AMAM

Ambrx Biopharma Inc.

AMAM
55 / 100
High Growth
$27.91arrow_drop_down-0.10%-$0.03

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Ambrx Biopharma Inc. (AMAM) Stocklytics Forecast

Ambrx Biopharma Inc. (AMAM) is a biopharmaceutical company that specializes in the development of innovative protein therapeutics. With a strong focus on leveraging its proprietary technology platform, the company is positioned to be a leader in the field of precision medicine. The stock price of AMAM has been subject to speculation and forecasting, with investors keen to understand its potential future performance. While it is challenging to predict the future stock price with certainty, there are several factors that could influence AMAM's future prospects.

One potential determinant of AMAM's stock price is its ongoing research and development efforts. As a biopharmaceutical company, AMAM's success is heavily dependent on its ability to develop and commercialize innovative therapies. Positive clinical trial results and successful product launches could potentially boost investor confidence and drive up the stock price. Conversely, any setbacks or delays in drug development could lead to a decline in stock price.

add Ambrx Biopharma Inc. to watchlist

Keep an eye on Ambrx Biopharma Inc.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is the analyst price prediction for Ambrx Biopharma Inc. (AMAM) stock?

Analysts have set a target price of $18.89 for Ambrx Biopharma Inc. (AMAM), based on forecasts from 18 analysts. The predicted price range extends from a high of $33 to a low of $4. This represents a potential increase of up to 18.07% and a decrease of -85.69% from the current price of $27.95. These forecasts are as of 2021 Jul 13.

question_mark
What are the analyst ratings for Ambrx Biopharma Inc. (AMAM) stock?

Currently, there are no analyst ratings available for Ambrx Biopharma Inc. (AMAM), possibly due to insufficient coverage or recent updates.

question_mark
What is the AI price prediction for Ambrx Biopharma Inc. (AMAM) stock?

At present, there is no AI or machine-learning-based price prediction available for Ambrx Biopharma Inc. (AMAM) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.